HEADER HYDROLASE 19-APR-01 1IHD TITLE CRYSTAL STRUCTURE OF TRIGONAL FORM OF D90E MUTANT OF ESCHERICHIA COLI TITLE 2 ASPARAGINASE II COMPND MOL_ID: 1; COMPND 2 MOLECULE: L-ASPARAGINASE II; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: L-ASNASE II; COMPND 5 EC: 3.5.1.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS L-ASPARAGINASE, LEUKEMIA, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR D.BOREK,M.JASKOLSKI REVDAT 5 27-OCT-21 1IHD 1 SEQADV REVDAT 4 19-OCT-16 1IHD 1 JRNL REVDAT 3 13-JUL-11 1IHD 1 VERSN REVDAT 2 24-FEB-09 1IHD 1 VERSN REVDAT 1 09-SEP-03 1IHD 0 JRNL AUTH D.BOREK,M.KOZAK,J.PEI,M.JASKOLSKI JRNL TITL CRYSTAL STRUCTURE OF ACTIVE SITE MUTANT OF ANTILEUKEMIC JRNL TITL 2 L-ASPARAGINASE REVEALS CONSERVED ZINC-BINDING SITE. JRNL REF FEBS J. V. 281 4097 2014 JRNL REFN ISSN 1742-464X JRNL PMID 25040257 JRNL DOI 10.1111/FEBS.12906 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.L.SWAIN,M.JASKOLSKI,D.HOUSSET,J.K.RAO,A.WLODAWER REMARK 1 TITL CRYSTAL STRUCTURE OF ESCHERICHIA COLI L-ASPARAGINASE, AN REMARK 1 TITL 2 ENZYME USED IN CANCER THERAPY REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 90 1474 1993 REMARK 1 REFN ISSN 0027-8424 REMARK 1 REFERENCE 2 REMARK 1 AUTH G.J.PALM,J.LUBKOWSKI,C.DERST,S.SCHLEPER,K.H.ROHM,A.WLODAWER REMARK 1 TITL A COVALENTLY BOUND CATALYTIC INTERMEDIATE IN ESCHERICHIA REMARK 1 TITL 2 COLI ASPARAGINASE: CRYSTAL STRUCTURE OF A THR-89-VAL MUTANT REMARK 1 REF FEBS LETT. V. 390 211 1996 REMARK 1 REFN ISSN 0014-5793 REMARK 1 DOI 10.1016/0014-5793(96)00660-6 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.JASKOLSKI,M.KOZAK,J.LUBKOWSKI,G.PALM,A.WLODAWER REMARK 1 TITL STRUCTURES OF TWO HIGHLY HOMOLOGOUS BACTERIAL REMARK 1 TITL 2 L-ASPARAGINASES: A CASE OF ENANTIOMORPHIC SPACE GROUPS REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 57 369 2001 REMARK 1 REFN ISSN 0907-4449 REMARK 1 DOI 10.1107/S0907444900020175 REMARK 1 REFERENCE 4 REMARK 1 AUTH D.T.BONTHRON,M.JASKOLSKI REMARK 1 TITL WHY A "BENIGN" MUTATION KILLS ENZYME ACTIVITY. REMARK 1 TITL 2 STRUCTURE-BASED ANALYSIS OF THE A176V MUTANT OF REMARK 1 TITL 3 SACCHAROMYCES CEREVISIAE L-ASPARAGINASE I REMARK 1 REF ACTA BIOCHIM.POL. V. 44 491 1997 REMARK 1 REFN ISSN 0001-527X REMARK 1 REFERENCE 5 REMARK 1 AUTH H.P.AUNG,M.BOCOLA,S.SCHLEPER,K.H.ROHM REMARK 1 TITL DYNAMICS OF A MOBILE LOOP AT THE ACTIVE SITE OF ESCHERICHIA REMARK 1 TITL 2 COLI ASPARAGINASE REMARK 1 REF BIOCHIM.BIOPHYS.ACTA V.1481 349 2000 REMARK 1 REFN ISSN 0006-3002 REMARK 1 DOI 10.1016/S0167-4838(00)00179-5 REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 19606 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.169 REMARK 3 R VALUE (WORKING SET) : 0.166 REMARK 3 FREE R VALUE : 0.209 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1065 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4610 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 54 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 54.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.42 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.23000 REMARK 3 B22 (A**2) : -0.23000 REMARK 3 B33 (A**2) : 0.35000 REMARK 3 B12 (A**2) : -0.12000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 1.018 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.276 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.216 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.209 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.014 ; 0.022 REMARK 3 ANGLE DISTANCE (A) : 1.535 ; 1.952 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : 3.768 ; 3.000 REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : 0.005 ; 0.020 REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : 0.098 ; 0.200 REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.437 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 0.815 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.486 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.483 ; 4.500 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 MAXIMUM LIKELIHOOD ALGORITHM. TLS PARAMETERS WERE USED. REMARK 3 RESIDUES 16-34 IN MOLECULE A AND RESIDUES 16-33 IN MOLECULE B NOT REMARK 3 INCLUDED IN THE MODEL DUE TO POOR ELECTRON DENSITY. REMARK 4 REMARK 4 1IHD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-APR-01. REMARK 100 THE DEPOSITION ID IS D_1000013268. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAR-98 REMARK 200 TEMPERATURE (KELVIN) : 290 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : SIEMENS REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21041 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.10900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.54200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: ACTIVE DIMER (AC) FROM NATIVE L-ASPARAGINASE II REMARK 200 STRUCTURE - PDB CODE: 3ECA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM CITRATE, HEPES, PH 7.5, 292 K, REMARK 280 VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 27.95800 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 55.91600 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 55.91600 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 27.95800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 300 THE BIOLOGICALLY SIGNIFICANT OLIGOMER IS A HOMOTETRAMER REMARK 300 WITH 222 SYMMETRY. THE ASYMMETRIC UNIT CONSIST OF MONOMERS REMARK 300 A AND C WHICH FORM THE ACTIVE-SITE-COMPETENT DIMER WITH REMARK 300 NON-CRYSTALLOGRAPHIC TWO-FOLD SYMMETRY. THE COMPLETE REMARK 300 TETRAMER IS GENERATED FROM THE AC DIMER THROUGH REMARK 300 CRYSTALLOGRAPHIC TWO-FOLD ROTATION. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 14310 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 41050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -55.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 83.87400 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 16 REMARK 465 GLY A 17 REMARK 465 ASP A 18 REMARK 465 SER A 19 REMARK 465 ALA A 20 REMARK 465 THR A 21 REMARK 465 LYS A 22 REMARK 465 SER A 23 REMARK 465 ASN A 24 REMARK 465 TYR A 25 REMARK 465 THR A 26 REMARK 465 VAL A 27 REMARK 465 GLY A 28 REMARK 465 LYS A 29 REMARK 465 VAL A 30 REMARK 465 GLY A 31 REMARK 465 VAL A 32 REMARK 465 GLU A 33 REMARK 465 ASN A 34 REMARK 465 GLY C 16 REMARK 465 GLY C 17 REMARK 465 ASP C 18 REMARK 465 SER C 19 REMARK 465 ALA C 20 REMARK 465 THR C 21 REMARK 465 LYS C 22 REMARK 465 SER C 23 REMARK 465 ASN C 24 REMARK 465 TYR C 25 REMARK 465 THR C 26 REMARK 465 VAL C 27 REMARK 465 GLY C 28 REMARK 465 LYS C 29 REMARK 465 VAL C 30 REMARK 465 GLY C 31 REMARK 465 VAL C 32 REMARK 465 GLU C 33 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU C 93 CD GLU C 93 OE1 -0.068 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 78 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 GLU A 93 OE1 - CD - OE2 ANGL. DEV. = -8.2 DEGREES REMARK 500 ASP A 106 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 ASP A 233 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 ASP A 285 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP C 60 CB - CG - OD2 ANGL. DEV. = 6.9 DEGREES REMARK 500 GLU C 93 OE1 - CD - OE2 ANGL. DEV. = -9.2 DEGREES REMARK 500 ASP C 106 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP C 285 CB - CG - OD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 ASP C 286 CB - CG - OD2 ANGL. DEV. = 6.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 166 -12.01 -143.44 REMARK 500 THR A 198 -116.00 35.69 REMARK 500 LYS A 251 -67.84 -21.07 REMARK 500 SER A 270 -163.91 -120.53 REMARK 500 ASP A 281 14.57 54.29 REMARK 500 ALA A 282 -72.00 -79.00 REMARK 500 THR C 166 -9.41 -145.13 REMARK 500 THR C 198 -114.06 34.82 REMARK 500 GLU C 210 148.07 -172.38 REMARK 500 LYS C 251 -66.91 -21.08 REMARK 500 SER C 270 -164.55 -123.52 REMARK 500 ASP C 281 15.25 55.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3ECA RELATED DB: PDB REMARK 900 STRUCTURE OF NATIVE ESCHERICHIA COLI ASPARAGINASE II REMARK 900 RELATED ID: 4ECA RELATED DB: PDB REMARK 900 STRUCTURE OF T89V MUTANT OF ESCHERICHIA COLI ASPARAGINASE II REMARK 900 RELATED ID: 1HO3 RELATED DB: PDB REMARK 900 STRUCTURE OF Y25F MUTANT OF ESCHERICHIA COLI ASPARAGINASE II REMARK 900 RELATED ID: 1AGX RELATED DB: PDB REMARK 900 STRUCTURE OF ACINETOBACTER GLUTAMINASIFICANS GLUTAMINASE REMARK 900 ASPARAGINASE REMARK 900 RELATED ID: 1DJO RELATED DB: PDB REMARK 900 STRUCTURE OF PSEUDOMONAS 7A GLUTAMINASE-ASPARAGINASE WITH THE REMARK 900 INHIBITOR DONV COVALENTLY BOUND IN THE ACTIVE SITE REMARK 900 RELATED ID: 1DJP RELATED DB: PDB REMARK 900 STRUCTURE OF PSEUDOMONAS 7A GLUTAMINASE-ASPARAGINASE WITH THE REMARK 900 INHIBITOR DON COVALENTLY BOUND IN THE ACTIVE SITE REMARK 900 RELATED ID: 1HFJ RELATED DB: PDB REMARK 900 ASPARAGINASE FROM ERWINIA CHRYSANTHEMI, HEXAGONAL FORM WITH SULFATE REMARK 900 RELATED ID: 1HFK RELATED DB: PDB REMARK 900 ASPARAGINASE FROM ERWINIA CHRYSANTHEMI, HEXAGONAL FORM WITH WEAK REMARK 900 SULFATE REMARK 900 RELATED ID: 1WSA RELATED DB: PDB REMARK 900 STRUCTURE OF WOLINELLA SUCCINOGENES L-ASPARAGINASE II PRECURSOR REMARK 900 RELATED ID: 3PGA RELATED DB: PDB REMARK 900 STRUCTURAL CHARACTERIZATION OF PSEUDOMONAS 7A GLUTAMINASE- REMARK 900 ASPARAGINASE REMARK 900 RELATED ID: 4PGA RELATED DB: PDB REMARK 900 GLUTAMINASE-ASPARAGINASE FROM PSEUDOMONAS 7A DBREF 1IHD A 1 326 UNP P00805 ASPG2_ECOLI 23 348 DBREF 1IHD C 1 326 UNP P00805 ASPG2_ECOLI 23 348 SEQADV 1IHD GLU A 90 UNP P00805 ASP 112 ENGINEERED MUTATION SEQADV 1IHD GLU C 90 UNP P00805 ASP 112 ENGINEERED MUTATION SEQRES 1 A 326 LEU PRO ASN ILE THR ILE LEU ALA THR GLY GLY THR ILE SEQRES 2 A 326 ALA GLY GLY GLY ASP SER ALA THR LYS SER ASN TYR THR SEQRES 3 A 326 VAL GLY LYS VAL GLY VAL GLU ASN LEU VAL ASN ALA VAL SEQRES 4 A 326 PRO GLN LEU LYS ASP ILE ALA ASN VAL LYS GLY GLU GLN SEQRES 5 A 326 VAL VAL ASN ILE GLY SER GLN ASP MET ASN ASP ASN VAL SEQRES 6 A 326 TRP LEU THR LEU ALA LYS LYS ILE ASN THR ASP CYS ASP SEQRES 7 A 326 LYS THR ASP GLY PHE VAL ILE THR HIS GLY THR GLU THR SEQRES 8 A 326 MET GLU GLU THR ALA TYR PHE LEU ASP LEU THR VAL LYS SEQRES 9 A 326 CYS ASP LYS PRO VAL VAL MET VAL GLY ALA MET ARG PRO SEQRES 10 A 326 SER THR SER MET SER ALA ASP GLY PRO PHE ASN LEU TYR SEQRES 11 A 326 ASN ALA VAL VAL THR ALA ALA ASP LYS ALA SER ALA ASN SEQRES 12 A 326 ARG GLY VAL LEU VAL VAL MET ASN ASP THR VAL LEU ASP SEQRES 13 A 326 GLY ARG ASP VAL THR LYS THR ASN THR THR ASP VAL ALA SEQRES 14 A 326 THR PHE LYS SER VAL ASN TYR GLY PRO LEU GLY TYR ILE SEQRES 15 A 326 HIS ASN GLY LYS ILE ASP TYR GLN ARG THR PRO ALA ARG SEQRES 16 A 326 LYS HIS THR SER ASP THR PRO PHE ASP VAL SER LYS LEU SEQRES 17 A 326 ASN GLU LEU PRO LYS VAL GLY ILE VAL TYR ASN TYR ALA SEQRES 18 A 326 ASN ALA SER ASP LEU PRO ALA LYS ALA LEU VAL ASP ALA SEQRES 19 A 326 GLY TYR ASP GLY ILE VAL SER ALA GLY VAL GLY ASN GLY SEQRES 20 A 326 ASN LEU TYR LYS SER VAL PHE ASP THR LEU ALA THR ALA SEQRES 21 A 326 ALA LYS THR GLY THR ALA VAL VAL ARG SER SER ARG VAL SEQRES 22 A 326 PRO THR GLY ALA THR THR GLN ASP ALA GLU VAL ASP ASP SEQRES 23 A 326 ALA LYS TYR GLY PHE VAL ALA SER GLY THR LEU ASN PRO SEQRES 24 A 326 GLN LYS ALA ARG VAL LEU LEU GLN LEU ALA LEU THR GLN SEQRES 25 A 326 THR LYS ASP PRO GLN GLN ILE GLN GLN ILE PHE ASN GLN SEQRES 26 A 326 TYR SEQRES 1 C 326 LEU PRO ASN ILE THR ILE LEU ALA THR GLY GLY THR ILE SEQRES 2 C 326 ALA GLY GLY GLY ASP SER ALA THR LYS SER ASN TYR THR SEQRES 3 C 326 VAL GLY LYS VAL GLY VAL GLU ASN LEU VAL ASN ALA VAL SEQRES 4 C 326 PRO GLN LEU LYS ASP ILE ALA ASN VAL LYS GLY GLU GLN SEQRES 5 C 326 VAL VAL ASN ILE GLY SER GLN ASP MET ASN ASP ASN VAL SEQRES 6 C 326 TRP LEU THR LEU ALA LYS LYS ILE ASN THR ASP CYS ASP SEQRES 7 C 326 LYS THR ASP GLY PHE VAL ILE THR HIS GLY THR GLU THR SEQRES 8 C 326 MET GLU GLU THR ALA TYR PHE LEU ASP LEU THR VAL LYS SEQRES 9 C 326 CYS ASP LYS PRO VAL VAL MET VAL GLY ALA MET ARG PRO SEQRES 10 C 326 SER THR SER MET SER ALA ASP GLY PRO PHE ASN LEU TYR SEQRES 11 C 326 ASN ALA VAL VAL THR ALA ALA ASP LYS ALA SER ALA ASN SEQRES 12 C 326 ARG GLY VAL LEU VAL VAL MET ASN ASP THR VAL LEU ASP SEQRES 13 C 326 GLY ARG ASP VAL THR LYS THR ASN THR THR ASP VAL ALA SEQRES 14 C 326 THR PHE LYS SER VAL ASN TYR GLY PRO LEU GLY TYR ILE SEQRES 15 C 326 HIS ASN GLY LYS ILE ASP TYR GLN ARG THR PRO ALA ARG SEQRES 16 C 326 LYS HIS THR SER ASP THR PRO PHE ASP VAL SER LYS LEU SEQRES 17 C 326 ASN GLU LEU PRO LYS VAL GLY ILE VAL TYR ASN TYR ALA SEQRES 18 C 326 ASN ALA SER ASP LEU PRO ALA LYS ALA LEU VAL ASP ALA SEQRES 19 C 326 GLY TYR ASP GLY ILE VAL SER ALA GLY VAL GLY ASN GLY SEQRES 20 C 326 ASN LEU TYR LYS SER VAL PHE ASP THR LEU ALA THR ALA SEQRES 21 C 326 ALA LYS THR GLY THR ALA VAL VAL ARG SER SER ARG VAL SEQRES 22 C 326 PRO THR GLY ALA THR THR GLN ASP ALA GLU VAL ASP ASP SEQRES 23 C 326 ALA LYS TYR GLY PHE VAL ALA SER GLY THR LEU ASN PRO SEQRES 24 C 326 GLN LYS ALA ARG VAL LEU LEU GLN LEU ALA LEU THR GLN SEQRES 25 C 326 THR LYS ASP PRO GLN GLN ILE GLN GLN ILE PHE ASN GLN SEQRES 26 C 326 TYR FORMUL 3 HOH *54(H2 O) HELIX 1 1 GLN A 41 ALA A 46 1 6 HELIX 2 2 GLY A 57 MET A 61 5 5 HELIX 3 3 ASN A 62 CYS A 77 1 16 HELIX 4 4 ASP A 78 THR A 80 5 3 HELIX 5 5 THR A 91 VAL A 103 1 13 HELIX 6 6 ASP A 124 ALA A 137 1 14 HELIX 7 7 ASP A 138 ALA A 142 5 5 HELIX 8 8 HIS A 197 THR A 201 5 5 HELIX 9 9 ASP A 225 ALA A 234 1 10 HELIX 10 10 TYR A 250 LYS A 262 1 13 HELIX 11 11 ASP A 285 GLY A 290 1 6 HELIX 12 12 ASN A 298 THR A 311 1 14 HELIX 13 13 ASP A 315 TYR A 326 1 12 HELIX 14 14 ASN C 34 VAL C 39 1 6 HELIX 15 15 GLN C 41 ALA C 46 1 6 HELIX 16 16 GLY C 57 MET C 61 5 5 HELIX 17 17 ASN C 62 CYS C 77 1 16 HELIX 18 18 ASP C 78 THR C 80 5 3 HELIX 19 19 THR C 91 VAL C 103 1 13 HELIX 20 20 ASP C 124 ALA C 137 1 14 HELIX 21 21 ASP C 138 ALA C 142 5 5 HELIX 22 22 HIS C 197 THR C 201 5 5 HELIX 23 23 ASP C 225 ALA C 234 1 10 HELIX 24 24 TYR C 250 THR C 263 1 14 HELIX 25 25 ASP C 285 GLY C 290 1 6 HELIX 26 26 ASN C 298 THR C 311 1 14 HELIX 27 27 ASP C 315 TYR C 326 1 12 SHEET 1 A 8 ASN A 47 GLN A 52 0 SHEET 2 A 8 ASN A 3 ALA A 8 1 N ILE A 4 O ASN A 47 SHEET 3 A 8 GLY A 82 THR A 86 1 O GLY A 82 N THR A 5 SHEET 4 A 8 VAL A 109 VAL A 112 1 O VAL A 110 N ILE A 85 SHEET 5 A 8 LEU A 147 MET A 150 1 N LEU A 147 O VAL A 109 SHEET 6 A 8 THR A 153 ASP A 156 -1 N THR A 153 O MET A 150 SHEET 7 A 8 GLY A 180 HIS A 183 -1 O GLY A 180 N VAL A 154 SHEET 8 A 8 LYS A 186 TYR A 189 -1 O LYS A 186 N HIS A 183 SHEET 1 B 2 VAL A 160 LYS A 162 0 SHEET 2 B 2 PHE A 171 SER A 173 -1 O LYS A 172 N THR A 161 SHEET 1 C 4 VAL A 214 TYR A 218 0 SHEET 2 C 4 GLY A 238 GLY A 243 1 O GLY A 238 N GLY A 215 SHEET 3 C 4 ALA A 266 SER A 271 1 O ALA A 266 N ILE A 239 SHEET 4 C 4 PHE A 291 ALA A 293 1 O VAL A 292 N ARG A 269 SHEET 1 D 8 ASN C 47 GLN C 52 0 SHEET 2 D 8 ASN C 3 ALA C 8 1 N ILE C 4 O ASN C 47 SHEET 3 D 8 GLY C 82 THR C 86 1 O GLY C 82 N THR C 5 SHEET 4 D 8 VAL C 109 VAL C 112 1 O VAL C 110 N ILE C 85 SHEET 5 D 8 LEU C 147 MET C 150 1 O LEU C 147 N MET C 111 SHEET 6 D 8 THR C 153 ASP C 156 -1 N THR C 153 O MET C 150 SHEET 7 D 8 GLY C 180 HIS C 183 -1 O GLY C 180 N VAL C 154 SHEET 8 D 8 LYS C 186 TYR C 189 -1 O LYS C 186 N HIS C 183 SHEET 1 E 2 VAL C 160 LYS C 162 0 SHEET 2 E 2 PHE C 171 SER C 173 -1 O LYS C 172 N THR C 161 SHEET 1 F 4 VAL C 214 TYR C 218 0 SHEET 2 F 4 GLY C 238 GLY C 243 1 O GLY C 238 N GLY C 215 SHEET 3 F 4 ALA C 266 SER C 271 1 O ALA C 266 N ILE C 239 SHEET 4 F 4 PHE C 291 ALA C 293 1 O VAL C 292 N ARG C 269 SSBOND 1 CYS A 77 CYS A 105 1555 1555 1.99 SSBOND 2 CYS C 77 CYS C 105 1555 1555 1.97 CRYST1 123.255 123.255 83.874 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008113 0.004684 0.000000 0.00000 SCALE2 0.000000 0.009368 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011923 0.00000 MASTER 397 0 0 27 28 0 0 6 0 0 0 52 END